ACTIVITY AND SAFETY OF A COMBINATION OF EPIRUBICIN, DOCETAXEL AND CISPLATIN AS NEOADJUVANT TREATMENT FOR LOCALLY ADVANCED BREAST CANCER (LABC): A PRELIMINARY REPORT | AVESİS

Bursa Uludag University Research Information System

ACTIVITY AND SAFETY OF A COMBINATION OF EPIRUBICIN, DOCETAXEL AND CISPLATIN AS NEOADJUVANT TREATMENT FOR LOCALLY ADVANCED BREAST CANCER (LABC): A PRELIMINARY REPORT

Copy For Citation

Avci N., Kanat O., Gokgoz S., Tolunay S., Topal U., Cubukcu E., ...More

37th Congress of the European-Society-for-Medical-Oncology (ESMO), Vienna, Austria, 28 September - 02 October 2012, vol.23, pp.129

Publication Type: Conference Paper / Summary Text
Volume: 23
City: Vienna
Country: Austria
Page Numbers: pp.129
Bursa Uludag University Affiliated: Yes